The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yao, Z. Q.
Right arrow Articles by Hahn, Y. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yao, Z. Q.
Right arrow Articles by Hahn, Y. S.
The Journal of Immunology, 2001, 167: 5264-5272.
Copyright © 2001 by The American Association of Immunologists

Hepatitis C Virus Core Protein Inhibits Human T Lymphocyte Responses by a Complement-Dependent Regulatory Pathway1 ,2

Zhi Qiang Yao, Duong Tony Nguyen, Apostolos I. Hiotellis and Young S. Hahn3

Department of Microbiology and Pathology, Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA 22908

Complement proteins are involved in early innate immune responses against pathogens and play a role in clearing circulating viral Ags from the blood of infected hosts. We have previously demonstrated that hepatitis C virus (HCV) core, the first protein to be expressed and circulating in the blood of infected individuals, inhibited human T cell proliferative response through interaction with the complement receptor, globular domain of C1q receptor (gC1qR). To investigate the mechanisms of HCV core/gC1qR-induced inhibition of T cell proliferation, we examined the effect of core protein on the early events in T cell activation. We found that HCV core inhibited phosphorylation of extracellular signal-regulated kinase (ERK) and mitogen-activated ERK kinase (MEK). HCV core-induced impairment of ERK/MEK mitogen-activated protein kinase resulted in the inhibition of IL-2 and IL-2R{alpha} gene transcription, which led to the inhibition of IL-2 production and high-affinity IL-2R expression. Importantly, the ability of anti-gC1qR Ab treatment to reverse HCV core-induced inhibition of ERK/MEK phosphorylation reveals that the interaction between HCV core and gC1qR is linked to the interference of ERK/MEK mitogen-activated protein kinase activation. These results imply that HCV core-induced blockage of intracellular events in T cell activation by a complement-dependent regulatory pathway may play a critical role in the establishment of HCV persistence during the acute phase of viral infection.




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. Sansonno, F. A. Tucci, B. Ghebrehiwet, G. Lauletta, E. I. B. Peerschke, V. Conteduca, S. Russi, P. Gatti, L. Sansonno, and F. Dammacco
Role of the Receptor for the Globular Domain of C1q Protein in the Pathogenesis of Hepatitis C Virus-Related Cryoglobulin Vascular Damage
J. Immunol., November 1, 2009; 183(9): 6013 - 6020.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
H. Ebinuma, N. Nakamoto, Y. Li, D. A. Price, E. Gostick, B. L. Levine, J. Tobias, W. W. Kwok, and K.-M. Chang
Identification and In Vitro Expansion of Functional Antigen-Specific CD25+ FoxP3+ Regulatory T Cells in Hepatitis C Virus Infection
J. Virol., May 15, 2008; 82(10): 5043 - 5053.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
K. R. Jerome
Viral Modulation of T-Cell Receptor Signaling
J. Virol., May 1, 2008; 82(9): 4194 - 4204.
[Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Lukens, M. W. Cruise, M. G. Lassen, and Y. S. Hahn
Blockade of PD-1/B7-H1 Interaction Restores Effector CD8+ T Cell Responses in a Hepatitis C Virus Core Murine Model
J. Immunol., April 1, 2008; 180(7): 4875 - 4884.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H.-Y. Jeong, Y.-J. Lee, S.-K. Seo, S.-W. Lee, S.-J. Park, J.-N. Lee, H.-S. Sohn, S. Yao, L. Chen, and I. Choi
Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection
J. Leukoc. Biol., March 1, 2008; 83(3): 755 - 764.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. N. Waggoner, C. H. T. Hall, and Y. S. Hahn
HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production
J. Leukoc. Biol., December 1, 2007; 82(6): 1407 - 1419.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
D. Sansonno, A. Carbone, V. De Re, and F. Dammacco
Hepatitis C virus infection, cryoglobulinaemia, and beyond
Rheumatology, April 1, 2007; 46(4): 572 - 578.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Q. Yao, S. N. Waggoner, M. W. Cruise, C. Hall, X. Xie, D. W. Oldach, and Y. S. Hahn
SOCS1 and SOCS3 Are Targeted by Hepatitis C Virus Core/gC1qR Ligation To Inhibit T-Cell Function
J. Virol., December 15, 2005; 79(24): 15417 - 15429.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. L. Eisen-Vandervelde, S. N. Waggoner, Z. Q. Yao, E. M. Cale, C. S. Hahn, and Y. S. Hahn
Hepatitis C Virus Core Selectively Suppresses Interleukin-12 Synthesis in Human Macrophages by Interfering with AP-1 Activation
J. Biol. Chem., October 15, 2004; 279(42): 43479 - 43486.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
Z. Q. Yao, A. Eisen-Vandervelde, S. N. Waggoner, E. M. Cale, and Y. S. Hahn
Direct Binding of Hepatitis C Virus Core to gC1qR on CD4+ and CD8+ T Cells Leads to Impaired Activation of Lck and Akt
J. Virol., June 15, 2004; 78(12): 6409 - 6419.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-H. Lee, R.-F. Chen, J.-W. Liu, W.-T. Yeh, J.-C. Chang, P.-M. Liu, H.-L. Eng, M.-C. Lin, and K. D. Yang
Altered p38 Mitogen-Activated Protein Kinase Expression in Different Leukocytes with Increment of Immunosuppressive Mediators in Patients with Severe Acute Respiratory Syndrome
J. Immunol., June 15, 2004; 172(12): 7841 - 7847.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Dolganiuc, K. Kodys, A. Kopasz, C. Marshall, T. Do, L. Romics Jr., P. Mandrekar, M. Zapp, and G. Szabo
Hepatitis C Virus Core and Nonstructural Protein 3 Proteins Induce Pro- and Anti-inflammatory Cytokines and Inhibit Dendritic Cell Differentiation
J. Immunol., June 1, 2003; 170(11): 5615 - 5624.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Ni, E. Hembrador, A. M. Di Bisceglie, I. M. Jacobson, A. H. Talal, D. Butera, C. M. Rice, T. J. Chambers, and L. B. Dustin
Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
J. Immunol., March 15, 2003; 170(6): 3429 - 3439.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Urbani, C. Boni, G. Missale, G. Elia, C. Cavallo, M. Massari, G. Raimondo, and C. Ferrari
Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C
J. Virol., November 13, 2002; 76(24): 12423 - 12434.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Soguero, M. Joo, K. A. Chianese-Bullock, D. T. Nguyen, K. Tung, and Y. S. Hahn
Hepatitis C Virus Core Protein Leads to Immune Suppression and Liver Damage in a Transgenic Murine Model
J. Virol., August 12, 2002; 76(18): 9345 - 9354.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.